KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 18 filers reported holding KALVISTA PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,867,112 | -53.4% | 276,200 | 0.0% | 0.04% | -53.2% |
| Q3 2022 | $4,008,000 | +118.2% | 276,200 | +99.0% | 0.08% | +243.5% |
| Q4 2021 | $1,837,000 | -84.2% | 138,821 | -79.1% | 0.02% | -85.0% |
| Q3 2021 | $11,616,000 | -27.2% | 665,681 | 0.0% | 0.15% | -28.5% |
| Q2 2021 | $15,950,000 | -54.8% | 665,681 | -51.5% | 0.21% | -59.1% |
| Q1 2021 | $35,272,000 | +10.6% | 1,373,000 | -18.3% | 0.52% | +7.0% |
| Q4 2020 | $31,903,000 | +50.8% | 1,680,000 | 0.0% | 0.49% | +18.1% |
| Q3 2020 | $21,151,000 | +4.0% | 1,680,000 | 0.0% | 0.41% | -6.3% |
| Q2 2020 | $20,328,000 | +58.2% | 1,680,000 | 0.0% | 0.44% | +6.2% |
| Q1 2020 | $12,852,000 | -57.0% | 1,680,000 | 0.0% | 0.42% | -50.7% |
| Q4 2019 | $29,921,000 | +53.5% | 1,680,000 | 0.0% | 0.84% | +30.9% |
| Q3 2019 | $19,488,000 | -41.3% | 1,680,000 | +12.0% | 0.64% | -36.2% |
| Q2 2019 | $33,225,000 | +29.0% | 1,500,000 | +66.7% | 1.01% | +14.0% |
| Q1 2019 | $25,758,000 | +44.9% | 900,000 | 0.0% | 0.89% | +12.6% |
| Q4 2018 | $17,775,000 | -10.7% | 900,000 | 0.0% | 0.79% | +7.7% |
| Q3 2018 | $19,899,000 | +172.3% | 900,000 | 0.0% | 0.73% | +141.3% |
| Q2 2018 | $7,308,000 | -14.3% | 900,000 | 0.0% | 0.30% | -24.1% |
| Q1 2018 | $8,532,000 | +23.4% | 900,000 | +26.9% | 0.40% | +10.8% |
| Q4 2017 | $6,913,000 | +162.2% | 709,000 | +79.0% | 0.36% | +141.6% |
| Q3 2017 | $2,637,000 | +92.9% | 396,000 | +108.5% | 0.15% | +75.3% |
| Q2 2017 | $1,367,000 | +78.5% | 189,900 | +93.6% | 0.08% | +66.7% |
| Q1 2017 | $766,000 | – | 98,100 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,719,576 | $25,679,000 | 12.37% |
| Vivo Capital, LLC | 1,618,296 | $30,731,000 | 1.37% |
| Opaleye Management Inc. | 470,203 | $8,929,000 | 1.17% |
| INTERWEST VENTURE MANAGEMENT CO | 388,766 | $7,383,000 | 0.92% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 177,433 | $3,369,000 | 0.92% |
| Ikarian Capital, LLC | 1,063,961 | $20,204,000 | 0.89% |
| Ghost Tree Capital, LLC | 200,000 | $3,798,000 | 0.85% |
| Logos Global Management LP | 490,000 | $9,305,000 | 0.80% |
| Eventide Asset Management | 1,680,000 | $31,903,000 | 0.49% |
| Affinity Asset Advisors, LLC | 45,000 | $855,000 | 0.45% |